Pharma Pulse 2/24/25: Picking Markets for a Global Launch Strategy, Semaglutide Holds Promise in Reducing Alcohol Cravings & more

Picking Markets for a Global Launch Strategy

John Arena, interim president of global pharma services at Cencora, discusses how companies must prepare for each market and its unique regulatory requirements.

Study Shows Semaglutide Holds Promise in Reducing Alcohol Cravings

Treatment with semaglutide yielded superior effects on drinking outcomes compared with existing therapies to reduce alcohol cravings.

Why AI Spending Isn’t Slowing Down

Soaring demand for reasoning models will consume electricity, microchips and data-center real estate for the foreseeable future.

Nuclera Appoints Seth Benson as Chief Financial Officer

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced that it has appointed Seth Benson as Chief Financial Officer. Seth joins CEO, Dr Michael Chen, on the executive team to advance commercial and strategic initiatives, drive revenue and support expansion of the business following the close of the Company’s USD $75 million financing round.¹

LogiPharma on LinkedIn

🚀 Media Partner Announcement

We are thrilled to announce that LogiPharma 2025 have partnered with Pharmaceutical Commerce Magazine

Pharmaceutical Commerce Magazine is the credible industry resource on navigating the complex, vast, and value-critical journey points as drugs move from point of manufacture to point of dispensing. Exploring the business processes and technologies involved in how approved medicines go to market, the editorial content helps improve collaboration among biopharma decision makers, with the goal of reducing the cost of commercial operations.

👉🏼 Click here for the full media partner list:https://lnkd.in/g78EejgN

#LogiPharma #LogiPharma2025 #pharma #logistics #medtech #supplychain

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs